Abstract:Background and objective: Acute respiratory distress syndrome (ARDS) is a severe, life-threatening medical condition characterized by poor oxygenation due to non-compliant lungs secondary diffuse alveolar damage. Encouragingly, the incidence of ARDS has declined steadily recently, attributed mainly to implementation of keystone guidelines and continuous research efforts. Mechanical ventilation is the cornerstone of supportive care for ARDS patients. This review aims to consolidate the current knowledge on pneumothorax (PNX) and pneumomediastinum (PMD) and to enhance the understanding of the readers. The objectives are to (I) explore the etiology and risk factors of PNX and PMD, (II) discuss the various diagnostic modalities available, (III) evaluate management options, and (IV) recent advancements. Methods: A search of the literature was conducted using PubMed, MEDLINE, and Google Scholar for relevant articles pertaining to PNX and PMD in ARDS population. The clinical presentation, diagnostic and management strategies of PNX, PMD, and ARDS were summarized, and all authors reviewed the selection and decide which studies to include. Key content and findings: The adoption of lung-protective ventilation strategies, based on the review of literature from the recent years, shows that it has played a significant role in reducing the occurrence of barotrauma, such as PNX and PMD. However, PNX and PMD remains to be a challenging complication to manage. With a specific focus on PNX and PMD, this review provides valuable insights into effectively managing and understanding these critical complications among ARDS patients. Conclusions: ARDS, with its evolving definition, continues to pose a life-threatening threat. Despite the widespread adoption of lung-protective ventilation strategies, PNX and PMD present persistent challenges in management. Further research is imperative to enhance the risk assessment of ARDS patients prone to developing PNX and PMD and to institute more effective prevention and treatment measures.

Challenges in ARDS Definition, Management, and Identification of Effective Personalized Therapies

Personalized Respiratory Support in ARDS: A Physiology-to-Bedside Review

Promises and challenges of personalized medicine to guide ARDS therapy

Management of ARDS - What Works and What Does Not

Recent advances in the understanding and management of ARDS

Innovations in protective mechanical ventilation for acute respiratory distress syndrome management

Management of the acute respiratory distress syndrome

Pharmacotherapy of acute respiratory distress syndrome

Acute Respiratory Distress Syndrome: Bench-to-Bedside Approaches to Improve Drug Development.

[Challenges in Clinical Diagnosis of Acute Respiratory Distress Syndrome].

Emerging pharmacological therapies for ARDS: COVID-19 and beyond

Challenges in Transitioning from Controlled to Assisted Ventilation in Acute Respiratory Distress Syndrome (ARDS) Management

Acute Respiratory Distress Syndrome: Bench‐to‐Bedside Approaches to Improve Drug Development

Mechanical ventilation in patients with acute respiratory distress syndrome: current status and future perspectives

Acute respiratory distress syndrome

Acute respiratory distress syndrome: A review of ARDS across the life course

Personalized ventilation adjustment in ARDS: A systematic review and meta-analysis of image, driving pressure, transpulmonary pressure, and mechanical power

Opportunities for improved clinical trial designs in acute respiratory distress syndrome

Advancing precision medicine for acute respiratory distress syndrome

Pneumomediastinum and pneumothorax in acute respiratory distress syndrome (ARDS) patients: a narrative review

Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS)